首页|期刊导航|中国药理学与毒理学杂志|Direction of new drug research: soft regulation of inflammatory immune responses
Direction of new drug research: soft regulation of inflammatory immune responsesOA北大核心CSCDCSTPCD
Direction of new drug research: soft regulation of inflammatory immune responses
Wei WEI
Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei 230032, China
inflammatory immune responsessoft regulation of inflammatory immune responsescellular signal transductiondiscovery of new drugs
inflammatory immune responsessoft regulation of inflammatory immune responsescellular signal transductiondiscovery of new drugs
《中国药理学与毒理学杂志》 2017 (10)
942-943,2
The project supported by National Natural Science Foundation of China (81330081 and 81673444)
评论